Naoko Takebe

Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.

N. Takahashi, S. Puri, Amin H. Nassar, 2024, Nature reviews. Clinical oncology.

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

S. Roy-Chowdhuri, K. Janeway, A. Jaju, 2024, The Oncologist.